Add like
Add dislike
Add to saved papers

Femoral artery pseudoaneurysms in intravenous drug users: a 12-year series.

AIM: Management of pseudoaneurysms in intravenous drug users poses many questions regarding need for revascularization and type of surgery. The aim of this study was to report on the frequency and management of femoral artery pseudoaneurysms in our department during the last twelve years.

METHODS: Retrospective report on patients hospitalized in the Department of Vascular Surgery in Red Cross Hospital, Athens, Greece between January 1999 and May 2010 with femoral artery pseudoaneurysms due to intravenous drug abuse.

RESULTS: Overall, 23 patients (18 men, 5 women, mean age 36 years) were identified. Of these, 20 patients underwent revascularization, while femoral artery ligation had to be performed in 3. Intraoperative evaluation of leg perfusion was decisive in choice of treatment. No patient presented with critical limb ischemia postoperatively. No amputations or complications were noted during the follow-up.

CONCLUSION: Treatment of common femoral artery pseudoaneurysms in drug abusers should be tailored to individual requirements. Bypass surgery is not always required, due to the pre-existing collateral network in many cases.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app